Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Baxter recalled several lots of Ondansetron injections in US for pH failure in November 2023. The Class II recall is initiated by Baxter Healthcare Corporation, US. The batches were manufactured by Baxter, India at Ahmedabad. The recalled batches were first distributed in June 2022. Ondansetron injection is indicated for nausea and vomiting for post operative patients and nausea and vomiting associated with chemotherapy.
Leave a Comment
You must be logged in to post a comment.